home / stock / lab / lab news


LAB News and Press, Standard BioTools Inc.

Stock Information

Company Name: Standard BioTools Inc.
Stock Symbol: LAB
Market: NASDAQ

Menu

LAB LAB Quote LAB Short LAB News LAB Articles LAB Message Board
Get LAB Alerts

News, Short Squeeze, Breakout and More Instantly...

LAB - Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers

SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSA XT system from Carterra ® , a leading provider of high-throughput large and small molecule screening and characteriza...

LAB - Lab Instrument Industry Update - New Commercial Entrants

2024-05-23 09:17:40 ET Summary Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry high risks. Cytek stands out as the best opport...

LAB - Labrador Gold Provides Update on Sale of Kingsway Project

TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V:LAB | OTCQX:NKOSF | FNR:2N6) (“ LabGold ” or the “ Company ”) is pleased to announce that further to its press release dated April 22, 2024, the Company is providing an update on the sale of t...

LAB - Standard BioTools Inc. (LAB) Q1 2024 Earnings Call Transcript

2024-05-11 12:45:27 ET Standard BioTools Inc. (LAB) Q1 2024 Earnings Conference Call May 08, 2024, 4:30 PM ET Company Participants David Holmes - Investor Relations Michael Egholm - President and Chief Executive Officer Jeff Black - Chief Financial Officer Ad...

LAB - Standard BioTools GAAP EPS of -$0.27 misses by $0.15, revenue of $45.54M misses by $0.46M

2024-05-08 16:37:33 ET More on Standard BioTools Standard BioTools Inc. (LAB) Q4 2023 Earnings Call Transcript Standard BioTools Q1 2024 Earnings Preview Standard Biotools announces operational restructuring plan including headcount reduction Seeking Alpha&#x...

LAB - Standard BioTools Reports First Quarter 2024 Financial Results

Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025 Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of app...

LAB - Expected US Company Earnings on Wednesday, May 8th, 2024

Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...

LAB - Notable earnings after Wednesday's close

2024-05-07 17:35:59 ET Major earnings expected after the bell on Wednesday include: Energy Transfer LP ( ET ) Airbnb ( ABNB ) The Trade Desk ( TTD ) AMC Entertainment Holdings ( AMC ) Innovative Industrial Properties ( IIPR ) Read the full a...

LAB - Standard Biotools announces operational restructuring plan including headcount reduction

2024-04-25 09:18:10 ET More on Standard BioTools Standard BioTools Inc. (LAB) Q4 2023 Earnings Call Transcript Standard BioTools enters strategic engagement with Bristol Myers for expanded use of SomaScan platform Standard BioTools exchanges all outstanding Series B ...

LAB - Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth

Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025 Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 conference call SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLO...

Next 10